1. De Leyn, P, Dooms, C, Kuzdzal, J, et al. Preoperative mediastinal lymph node staging for non-small cell lung cancer: 2014 update of the 2007 ESTS guidelines. Transl Lung Cancer Res 2014; 3: 225–233.
Google Scholar | Medline2. Detterbeck, F, Puchalski, J, Rubinowitz, A, et al. Classification of the thoroughness of mediastinal staging of lung cancer. Chest 2010; 137: 436–442.
Google Scholar | Crossref | Medline3. Witte, B, Hurtgen, M. Video-assisted mediastinoscopic lymphadenectomy (VAMLA). J Thorac Oncol 2007; 2: 367–369.
Google Scholar | Crossref | Medline4. Hurtgen, M, Friedel, G, Toomes, H, et al. Radical video-assisted mediastinoscopic lymphadenectomy (VAMLA): technique and first results. Eur J Cardiothorac Surg 2002; 21: 348–351.
Google Scholar | Crossref | Medline5. Turna, A, Demirkaya, A, Özkul, S, et al. Video-assisted mediastinoscopic lymphadenectomy is associated with better survival than mediastinoscopy in patients with resected non-small cell lung cancer. J Thorac Cardiovasc Surg 2013; 146: 774–780.
Google Scholar | Crossref | Medline6. Wang, WJ, Tao, Z, Gu, W, et al. Variation of blood T lymphocyte subgroups in patients with non- small cell lung cancer. Asian Pac J Cancer Prev 2013; 14: 4671–4673.
Google Scholar | Crossref | Medline7. Altorki, NK, Markowitz, JG, Gao, D, et al. The lung microenvironment: an important regulator of tumour growth and metastasis. Nat Rev Cancer 2019; 19: 9–31.
Google Scholar | Crossref | Medline8. Sun, H, Sun, C, Xiao, W, et al. Tissue-resident lymphocytes: from adaptive to innate immunity. Cell Mol Immunol 2019; 16: 205–215.
Google Scholar | Crossref | Medline9. Chen, L . Co-inhibitory molecules of the B7-CD28 family in the control of T-cell immunity. Nat Rev Immunol 2004; 4: 336–347.
Google Scholar | Crossref | Medline10. Zhang, Y, Huang, S, Gong, D, et al. Programmed death-1 upregulation is correlated with dysfunction of tumor-infiltrating CD8+ T lymphocytes in human non-small cell lung cancer. Cell Mol Immunol 2010; 7: 389–395.
Google Scholar | Crossref | Medline11. He, J, Hu, Y, Hu, M, et al. Development of PD-1/PD-L1 pathway in tumor immune microenvironment and treatment for non-small cell lung cancer. Sci Rep 2015; 5: 13110.
Google Scholar | Crossref | Medline12. Salmaninejad, A, Khoramshahi, V, Azani, A, et al. PD-1 and cancer: molecular mechanisms and polymorphisms. Immunogenetics 2018; 70: 73–86.
Google Scholar | Crossref | Medline13. Kuol, N, Stojanovska, L, Nurgali, K, et al. PD-1/PD-L1 in disease. Immunotherapy 2018; 10: 149–160.
Google Scholar | Crossref | Medline14. Yu, H, Boyle, AT, Zhou, C, et al. PD-L1 expression in lung cancer. J Thorac Oncol 2016; 11: 964–975.
Google Scholar | Crossref | Medline15. Huff, WX, Kwon, JH, Henriquez, M, et al. The evolving role of CD8(+) CD28(-) immunosenescent T cells in cancer immunology. Int J Mol Sci 2019; 20: 2810.
Google Scholar | Crossref16. Detterbeck, FC, Boffa, DJ, Kim, AW, et al. The Eighth Edition Lung Cancer Stage Classification. Chest 2017; 151: 193–203.
Google Scholar | Crossref | Medline17. Misiak, J, Tarte, K, Ame-Thomas, P. Flow cytometric detection and isolation of human tonsil or lymph node T follicular helper cells. Methods Mol Biol 2015; 1291: 163–173.
Google Scholar | Crossref | Medline18. Stankovic, B, Bjørhovde, HAK, Skarshaug, R, et al. Immune cell composition in human non-small cell lung cancer. Front Immunol 2018. 9: 3101.
Google Scholar | Crossref | Medline19. Karagoz, B, Bilgi, O, Gümüs, M, et al. CD8+CD28- cells and CD4+CD25+ regulatory T cells in the peripheral blood of advanced stage lung cancer patients. Med Oncol 2010; 27: 29–33.
Google Scholar | Crossref | Medline20. Domagala-Kulawik, J . The role of the immune system in non-small cell lung carcinoma and potential for therapeutic intervention. Transl Lung Cancer Res 2015; 4: 177–190.
Google Scholar | Medline21. Ma, H, Mao, G, Zhang, G, et al. The expression and clinical signification of PD-1 in lymph nodes of patients with non-small cell lung cancer. Immunol Invest 2017; 46: 639–646.
Google Scholar | Crossref | Medline22. Arrieta, O, Montes-Servin, E, Hermandez Martinez, JM, et al. Expression of PD-1/PD-L1 and PD-L2 in peripheral T-cells from non-small cell lung cancer patients. Oncotarget 2017; 8: 101994–102005.
Google Scholar | Crossref | Medline23. Rutkowski, J, Cyman, M, Slebioda, T, et al. Evaluation of peripheral blood T lymphocyte surface activation markers and transcription factors in patients with early stage non-small cell lung cancer. Cell Immunol 2017; 322: 26–33.
Google Scholar | Crossref | Medline24. Sheng, S.Y, Gu, Y, Lu, C, et al. The distribution and function of human memory T cell subsets in lung cancer. Immunol Res 2017; 65: 639–650.
Google Scholar | Crossref | Medline25. Liu, Q, Hu, P, Deng, G, et al. Soluble cytotoxic T-lymphocyte antigen 4: a favorable predictor in malignant tumors after therapy. Oncol Targets Ther 2017; 10: 2147–2154.
Google Scholar | Crossref | Medline